Braun Stacey Associates Inc. Buys 900 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Braun Stacey Associates Inc. grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 221,509 shares of the company’s stock after acquiring an additional 900 shares during the period. Braun Stacey Associates Inc.’s holdings in GE HealthCare Technologies were worth $17,318,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. LGT Financial Advisors LLC grew its stake in shares of GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 251 shares during the last quarter. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Ashton Thomas Securities LLC purchased a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the third quarter valued at $31,000. Finally, Continuum Advisory LLC lifted its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $92.21 on Tuesday. The business’s fifty day simple moving average is $84.24 and its 200-day simple moving average is $85.60. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $42.13 billion, a PE ratio of 25.33, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were paid a dividend of $0.035 per share. The ex-dividend date of this dividend was Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on GEHC. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.